Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The new screenshot shows only minor UI and version history updates on the Record History page; core trial details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:25:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.
    Difference
    10%
    Check dated 2025-10-06T05:49:24.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Update: page now shows Revision: v3.1.0, replacing Revision: v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-29T03:09:04.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2, indicating a patch update to the page. The 'Back to Top' navigation element has been removed.
    Difference
    0.6%
    Check dated 2025-09-14T19:25:59.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.6%
    Check dated 2025-09-07T16:47:04.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    32%
    Check dated 2025-08-31T12:04:48.000Z thumbnail image

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.